Overcoming resistance to reverse transcriptase inhibitors.
Pieribone
V
V
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D004279:DNA, Viral; D004352:Drug Resistance, Microbial / Q000235:genetics; D006678:HIV / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D006801:Humans; D009154:Mutation; D011810:Quinoxalines; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D011810:Quinoxalines; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; C093110:HBY 097